COVID-19: Vaccines and Therapeutics
FDA yesterday approved using baricitinib to treat COVID-19 in certain hospitalized adults, and warned not to use a Skippack Medical Lab test.
FDA issues updates on a COVID-19 monoclonal antibody and antiviral pill, and certain Fresenius Medical Care hemodialysis machines.
The guidance is intended to help state policymakers identify and address related issues during and after the public health emergency.
Based on an updated analysis, FDA said the risk of thrombosis with thrombocytopenia syndrome warrants limiting the vaccine to certain adults.
This webinar rural hospital executives and board leaders discuss how boards can work with all levels within their communities.
The report estimates the impact of COVID-19 vaccination during a five-month period shortly after the first vaccine was authorized and recommended for health care workers and elderly people in long-term care facilities.
Moderna today asked the Food and Drug Administration to authorize for emergency use its COVID-19 vaccine in children aged 6 months through 5 years.
Starting this week, the Administration will allow all pharmacies in the federal pharmacy program to order free oral antiviral treatments directly from the federal government, the White House announced today.
Advisory updates health care providers, others on recommended therapies for COVID-19.
The Food and Drug Administration today expanded its approval for remdesivir (Veklury) to include pediatric patients under age 12 who test positive for SARS-CoV-2 and are hospitalized or at high risk of progressing to severe COVID-19. The patient must be at least 28 days old and weigh at least…